Wuhan firm’s DPT vaccines ‘cleared’
Print Edition
A BATCH of DPT vaccines produced in Wuhan found to be substandard was an isolated case and the company has recalled all unused substandard vaccines, China’s drug regulator said on Tuesday.
Spot checks in 2017 found that a batch of 400,520 doses of DPT vaccines produced by Wuhan Institute of Biological Products Co failed to meet standards. The main cause of the defects was found to be a short-term failure in the packaging equipment, said a spokesperson with the State Drug Administration.
The spokesperson said all unused DPT vaccines found to be substandard have been recalled by the company and destroyed.
Tests on other batches of DTP vaccine produced by the firm showed they all met standards, the spokesperson added.
DPT refers to a combination of vaccines against three infectious diseases: diphtheria, pertussis, and tetanus.
Wuhan Institute of Biological Products Co was fined and its illegal gains confiscated.
The local drug regulator demanded the company rectify improper practices and ensure the normal operation of its equipment. An inspection conducted in March by the national drug regulator found that the company had completed the rectification process, according to the spokesperson.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
